Stock data

商之器 (8409)

商之器 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$31.44M, down 60.3% from a year earlier. EPS over the last four quarters totals NT$1.01.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 商之器 in Insightr